Triasima Portfolio Management inc. acquired a new stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 19,875 shares of the company's stock, valued at approximately $808,000. Triasima Portfolio Management inc. owned about 0.06% of Bowhead Specialty as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Summit Investment Advisors Inc. raised its position in shares of Bowhead Specialty by 66.4% in the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock valued at $43,000 after purchasing an additional 486 shares during the last quarter. SBI Securities Co. Ltd. purchased a new position in shares of Bowhead Specialty in the 1st quarter valued at approximately $44,000. US Bancorp DE purchased a new position in shares of Bowhead Specialty in the 4th quarter valued at approximately $76,000. KLP Kapitalforvaltning AS purchased a new position in shares of Bowhead Specialty in the 4th quarter valued at approximately $107,000. Finally, GAMMA Investing LLC raised its position in shares of Bowhead Specialty by 7,651.2% in the 1st quarter. GAMMA Investing LLC now owns 3,333 shares of the company's stock valued at $135,000 after purchasing an additional 3,290 shares during the last quarter.
Wall Street Analyst Weigh In
BOW has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research report on Tuesday, April 8th. Morgan Stanley increased their price target on shares of Bowhead Specialty from $36.00 to $39.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. JMP Securities increased their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the stock a "market outperform" rating in a report on Friday, April 11th. Piper Sandler assumed coverage on shares of Bowhead Specialty in a report on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 price target on the stock. Finally, Keefe, Bruyette & Woods increased their price target on shares of Bowhead Specialty from $43.00 to $45.00 and gave the stock an "outperform" rating in a report on Friday, May 9th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $39.67.
Check Out Our Latest Research Report on Bowhead Specialty
Bowhead Specialty Price Performance
NYSE:BOW traded down $0.25 during midday trading on Friday, hitting $33.69. The company's stock had a trading volume of 220,660 shares, compared to its average volume of 206,570. Bowhead Specialty Holdings Inc. has a fifty-two week low of $24.80 and a fifty-two week high of $42.29. The firm's 50 day moving average is $36.32 and its 200-day moving average is $36.02. The firm has a market cap of $1.10 billion, a P/E ratio of 23.70 and a beta of -0.60.
Bowhead Specialty (NYSE:BOW - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.01. The business had revenue of $174.85 million for the quarter, compared to analysts' expectations of $105.17 million. Bowhead Specialty had a net margin of 9.32% and a return on equity of 12.52%. As a group, analysts forecast that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current year.
About Bowhead Specialty
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Recommended Stories

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.